Will health insurance cover Evinacumab-Dgnb?
Are you wondering if your health insurance will cover Evinacumab (DGNB)? This article provides insights and information about the coverage of this medication, helping you understand the potential financial aspects involved. Stay informed and make confident decisions about your healthcare.
Read more
Secured with SHA-256 Encryption
Table of Contents
Insurance Content Managing Editor
Daniel S. Young began his professional career as chief editor of The Chanticleer, a Jacksonville State University newspaper. He also contributed to The Anniston Star, a local newspaper in Alabama. Daniel holds a BA in Communication and is pursuing an MA in Journalism & Media Studies at the University of Alabama. With a strong desire to help others protect their investments, Daniel has writt...
Daniel S. Young
Licensed Insurance Producer
Dani Best has been a licensed insurance producer for nearly 10 years. Dani began her insurance career in a sales role with State Farm in 2014. During her time in sales, she graduated with her Bachelors in Psychology from Capella University and is currently earning her Masters in Marriage and Family Therapy. Since 2014, Dani has held and maintains licenses in Life, Disability, Property, and Casualt...
Dani Best
Updated January 2025
In recent years
Frequently Asked Questions
Will health insurance cover the cost of Evinacumab-Dgnb?
Health insurance coverage for Evinacumab-Dgnb may vary depending on the specific insurance plan. It is recommended to contact your insurance provider to determine if this medication is covered.
What is Evinacumab-Dgnb?
Evinacumab-Dgnb is a medication used to treat certain genetic conditions that cause high levels of cholesterol in the blood.
What genetic conditions does Evinacumab-Dgnb treat?
Evinacumab-Dgnb is primarily used to treat a genetic condition called homozygous familial hypercholesterolemia (HoFH), which leads to extremely high cholesterol levels.
How does Evinacumab-Dgnb work?
Evinacumab-Dgnb works by targeting and blocking a protein called angiopoietin-like 3 (ANGPTL3), which plays a role in regulating cholesterol levels. By inhibiting this protein, Evinacumab-Dgnb helps lower cholesterol levels in individuals with certain genetic conditions.
What are the potential side effects of Evinacumab-Dgnb?
Common side effects of Evinacumab-Dgnb may include reactions at the injection site, flu-like symptoms, and allergic reactions. It is important to discuss potential side effects with a healthcare provider.
Is Evinacumab-Dgnb approved by the FDA?
Yes, Evinacumab-Dgnb has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of homozygous familial hypercholesterolemia (HoFH) in certain individuals.
Get a FREE Quote in Minutes
Insurance rates change constantly — we help you stay ahead by making it easy to compare top options and save.
Secured with SHA-256 Encryption
